Misetionamide
Product Specifications
UNSPSC Description
Misetionamide is an orally oxathiazin-like compound. Misetionamide is a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor with antineoplastic activity. Misetionamide can be used for the research of cancer[1].
Target Antigen
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/misetionamide.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S1(NCOCC1)=O
Molecular Weight
137.16
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information. 2022. 36(2):337.|[2]Jinih M, et al. Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer Cells. Anticancer Res. 2021 May;41(5):2247-2256.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147280/Misetionamide-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147280/Misetionamide-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
856785-75-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1404049-01 0.02 mg (E-Coli)
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Urease subunit beta (ureB)
Ask
View Details MBS1404049-02 0.1 mg (E-Coli)
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Urease subunit beta (ureB)
Ask
View Details